Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Gerich

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Gastroenterology|April 12, 2022
Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal SurgeryBenjamin L Cohen, Phillip Fleshner, Sunanda V Kane, et al.
Science Immunology|June 30, 2023
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cellsWilliam H Palmer, Laura Ann Leaton, Ana Campos Codo, et al.
Nature Communications|September 13, 2024
HIF-2α-dependent induction of miR-29a restrains T<sub>H</sub>1 activity during T cell dependent colitisAgnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, et al.
BMJ Open Gastroenterology|March 31, 2025
Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trialSiddharth Singh, Jasmine D Nguyen, David I Fudman, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Gastroenterology|April 12, 2022
Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal SurgeryBenjamin L Cohen, Phillip Fleshner, Sunanda V Kane, et al.
Science Immunology|June 30, 2023
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cellsWilliam H Palmer, Laura Ann Leaton, Ana Campos Codo, et al.
Nature Communications|September 13, 2024
HIF-2α-dependent induction of miR-29a restrains T<sub>H</sub>1 activity during T cell dependent colitisAgnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, et al.
BMJ Open Gastroenterology|March 31, 2025
Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trialSiddharth Singh, Jasmine D Nguyen, David I Fudman, et al.
Pageof 4